Support for safe research on infectious agents and biodefense
Official title: Facility Management, Maintenance and Operation Core
Funded at University of Tennessee Health Sci Ctr · NIH-10910180 · Data updated 2026-11-12
This study is all about making sure that a special lab at the University of Tennessee Health Science Center is safe and ready for researchers to study germs and find ways to protect us from them, helping to improve health for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tennessee Health Sci Ctr NIH-funded |
| Lab location | 1 site (Memphis, United States) |
| Project start | August 18, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $882,711 |
| NIH project number | 5UC7AI180313-02 |
| Project ID | NIH-10910180 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include individuals affected by infectious diseases or those at risk of exposure to emerging pathogens.
✕Less likely to help
Patients who are not dealing with infectious diseases or who do not require advanced biosafety measures may not receive direct benefits from this research.
What this research studies
This research focuses on maintaining and operating specialized laboratory facilities that are essential for studying infectious agents and developing countermeasures for biodefense. The University of Tennessee Health Science Center's Regional Biocontainment Laboratory ensures that researchers have the necessary infrastructure, equipment, and safety measures in place to conduct their work safely. This includes regular maintenance, certification, and decontamination processes to uphold biosafety standards. By providing these critical services, the facility supports both basic and translational research efforts that address unmet medical needs.
Why it matters
Potential benefit: If successful, this research could enhance the safety and effectiveness of studies aimed at combating infectious diseases, ultimately leading to better treatments and preventive measures for patients.
How similar studies have gone: Other research facilities with similar biosafety measures have successfully contributed to advancements in infectious disease research, indicating that this approach is both tested and effective.
Where this research is happening
-
University of Tennessee Health Sci Ctr
Memphis, United States Active
Researchers
- Principal investigator: Fitzpatrick, Elizabeth Ann — University of Tennessee Health Sci Ctr
- Study coordinator: Fitzpatrick, Elizabeth Ann
Related research
Other NIH-funded projects on the same topics.
-
EP2 blockers to protect the brain after a stroke
Aims to test brain-permeable EP2 antagonists to reduce damage after ischemic stroke and improve recovery.
-
HIV drugs may also stop a dangerous fungus from growing
A cancer/antifungal researcher is exploring whether HIV medicines can help treat cryptococcal infections in people with HIV/AIDS.
-
Profiling immune cells to find early inflammation clues in kids with obesity and insulin resistance
This project looks at how immune cells in children with obesity may show early inflammatory changes linked to insulin resistance.
-
Targeted inhibitors to block a key enzyme and fight metastatic triple-negative breast cancer
A new drug candidate aimed at a specific enzyme in cancer cells is being developed to stop the spread of metastatic triple-negative breast cancer.
-
New fungal partner targets to curb Aspergillus infection in vulnerable patients
A NIH-funded project is exploring how the fungus Aspergillus fumigatus grows and causes serious infections in people with weakened immune systems, with the aim of finding new ways to stop it.
-
Epigenetic control of aging heart function
A scientist at a university is studying how aging changes heart function and whether a specific gene, KDM6A, influences this process to uncover ways to prevent or treat aging-related heart problems.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.